Portal de Periódicos da CAPES

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame

2015; Informa; Volume: 14; Issue: 8 Linguagem: Inglês

10.1586/14760584.2015.1052800

1744-8395

Edward P K Parker, Natalie A. Molodecky, Margarita Pons-Salort, Kathleen O’Reilly, Nicholas C. Grassly,

SARS-CoV-2 and COVID-19 Research

The polio eradication endgame aims to bring transmission of all polioviruses to a halt. To achieve this aim, it is essential to block viral replication in individuals via induction of a robust mucosal immune response. Although it has long been recognized that inactivated poliovirus vaccine (IPV) is incapable of inducing a strong mucosal response on its own, it has recently become clear that IPV may boost immunity in the intestinal mucosa among individuals previously immunized with oral poliovirus vaccine. Indeed, mucosal protection appears to be stronger following a booster dose of IPV than oral poliovirus vaccine, especially in older children. Here, we review the available evidence regarding the impact of IPV on mucosal immunity, and consider the implications of this evidence for the polio eradication endgame. We conclude that the implementation of IPV in both routine and supplementary immunization activities has the potential to play a key role in halting poliovirus transmission, and thereby hasten the eradication of polio.